Report cover image

Ringworm Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035

Publisher BIS Research
Published Oct 29, 2025
SKU # BIS20495253

Description

Global Ringworm Market, Analysis and Forecast: 2025-2035

The global ringworm market is positioned for steady expansion, driven by escalating prevalence of dermatophytosis, ongoing innovation in antifungal therapies, and growing investment in healthcare infrastructure across the U.S., Europe, and emerging economies. Development of advanced treatment options such as novel topical and oral antifungal formulations, including nanocarrier systems and sustained-release gels, is reshaping the global ringworm market landscape by enhancing therapeutic efficacy and patient compliance. As awareness rises regarding the consequences of untreated ringworm, including persistent dermatological infections, secondary bacterial colonization, and potential systemic complications, the demand for timely and effective treatments continues to accelerate.

Ongoing innovations in the development of more effective and targeted antifungal agents are expanding treatment options. Newer drugs with fewer side effects, and formulations designed to target drug-resistant strains, are contributing to improved efficacy and expanding market offerings.

The global ringworm market is further supported by rising emphasis on skin health in both developed markets, such as the U.S. and the U.K., and in emerging regions. Growing public health campaigns, hygiene awareness programs, and broader OTC access are elevating disease recognition and management standards. In addition, climatic conditions in tropical and humid areas, increased participation in contact sports, and intimate communal environments continue to drive incidence rates and treatment demand.

The challenges of the market are the development of more effective antifungal agents, improved diagnostic techniques, and better patient education to enhance treatment adherence. Additionally, the regulation of over-the-counter antifungal medications and global collaboration in research and healthcare access can help mitigate these barriers. As innovation continues, the market's trajectory will depend on overcoming these hurdles to ensure better outcomes for patients worldwide.

Looking ahead, the global ringworm market is projected to maintain a robust compound annual growth rate, supported by therapeutic innovation, enhanced diagnostic capabilities, and a growing preference for accessible treatment options across both OTC and prescription segments. The global ringworm market thus stands as a vital component within dermatological care, with significant potential to improve patient outcomes and contribute to global healthcare delivery.

The global ringworm market is poised for steady growth, driven by advancements in antifungal therapies and enhanced delivery technologies. Expanding healthcare infrastructure across the U.S., Europe, and emerging markets is expected to bolster market reach and accessibility. Advanced therapeutic innovations, including nanocarrier-based topical formulations, sustained‑release creams, and novel oral agents, are reshaping the global ringworm market by improving treatment effectiveness and patient adherence.

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

Table of Contents

Executive Summary
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1. Markets: Industry Outlook
1.1 Trends: Current and Future Impact Assessment
1.2 Epidemiological Analysis
1.3 Regulatory Landscape
1.4 Pipeline Analysis
1.5 Pricing Analysis
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.1.1 Impact Analysis
1.6.2 Market Restraints
1.6.2.1 Impact Analysis
1.6.3 Market Opportunities
1.6.3.1 Impact Analysis
2. Global Ringworm Market (by Region), ($Million) 2024-2035
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Sizing and Forecast
2.1.2.1 North America Ringworm Market (by Country)
2.1.2.1.1 U.S.
2.1.2.1.2 Rest-of-North-America
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Sizing and Forecast
2.2.2.1 Europe Ringworm Market (by Country)
2.2.2.1.1 Germany
2.2.2.1.2 France
2.2.2.1.3 U.K.
2.2.2.1.4 Spain
2.2.2.1.5 Italy
2.2.2.1.6 Rest-of-Europe
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Sizing and Forecast
2.3.2.1 Asia-Pacific Ringworm Market (by Country)
2.3.2.1.1 Japan
2.3.2.1.2 Rest-of-Asia-Pacific
2.4 Rest-of-the-World
2.4.1 Market Dynamics
2.4.2 Market Sizing and Forecast
3. Global Ringworm Market - Competitive Benchmarking & Company Profiles
3.1 Key Strategies and Development
3.1.1 Mergers and Acquisitions
3.1.2 Partnership, Alliances and Business Expansion
3.1.3 New Offerings
3.1.4 Regulatory Activities
3.1.5 Funding Activities
3.2 Company Profiles
3.2.1 Bayer AG
3.2.1.1 Overview
3.2.1.2 Top Products/Product Portfolio
3.2.1.3 Top Competitors
3.2.1.4 Target Customers
3.2.1.5 Key Personnel
3.2.1.6 Analyst View
3.2.2 Karo Healthcare AB
3.2.2.1 Overview
3.2.2.2 Top Products/Product Portfolio
3.2.2.3 Top Competitors
3.2.2.4 Target Customers
3.2.2.5 Key Personnel
3.2.2.6 Analyst View
3.2.3 GlaxoSmithKline Plc
3.2.3.1 Overview
3.2.3.2 Top Products/Product Portfolio
3.2.3.3 Top Competitors
3.2.3.4 Target Customers
3.2.3.5 Key Personnel
3.2.3.6 Analyst View
3.2.4 Teva Pharmaceuticals Industries Ltd.
3.2.4.1 Overview
3.2.4.2 Top Products/Product Portfolio
3.2.4.3 Top Competitors
3.2.4.4 Target Customers
3.2.4.5 Key Personnel
3.2.4.6 Analyst View
3.2.5 Glenmark Pharmaceuticals
3.2.5.1 Overview
3.2.5.2 Top Products/Product Portfolio
3.2.5.3 Top Competitors
3.2.5.4 Target Customers
3.2.5.5 Key Personnel
3.2.5.6 Analyst View
3.2.6 Perrigo Company Plc
3.2.6.1 Overview
3.2.6.2 Top Products/Product Portfolio
3.2.6.3 Top Competitors
3.2.6.4 Target Customers
3.2.6.5 Key Personnel
3.2.6.6 Analyst View
3.2.7 Sun Pharma (Taro Pharmaceutical Industries)
3.2.7.1 Overview
3.2.7.2 Top Products/Product Portfolio
3.2.7.3 Top Competitors
3.2.7.4 Target Customers
3.2.7.5 Key Personnel
3.2.7.6 Analyst View
3.2.8 Reckitt Benckiser Group Plc
3.2.8.1 Overview
3.2.8.2 Top Products/Product Portfolio
3.2.8.3 Top Competitors
3.2.8.4 Target Customers
3.2.8.5 Key Personnel
3.2.8.6 Analyst View
3.2.9 Actiza Pharmaceutical Pvt. Ltd.
3.2.9.1 Overview
3.2.9.2 Top Products/Product Portfolio
3.2.9.3 Top Competitors
3.2.9.4 Target Customers
3.2.9.5 Key Personnel
3.2.9.6 Analyst View
3.2.10 Others
4. Research Methodology
List of Figures
Figure: Global Ringworm Market, 2024 and 2035
Figure: Global Ringworm Market Key Trends, Impact Analysis, 2024-2035
Figure: North America Ringworm Market, $Million, 2024-2035
Figure: Europe Ringworm Market, $Million, 2024-2035
Figure: Asia-Pacific Ringworm Market, $Million, 2024-2035
List of Tables
Table: Market Snapshot
Table: Global Ringworm Market, Dynamics Impact Analysis
Table: Global Ringworm Market (by Region), $Million, 2024-2035

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us